Cargando…

Psychedelic Fauna for Psychonaut Hunters: A Mini-Review

Currently different classes of psychoactive substances are easily available for abuse, including several hundred novel psychoactive substances (NPS). Some of these drugs occur naturally in plants and animals or are chemically modified from plant or animal compounds and have been abused by humans ove...

Descripción completa

Detalles Bibliográficos
Autores principales:	Orsolini, Laura, Ciccarese, Michela, Papanti, Duccio, De Berardis, Domenico, Guirguis, Amira, Corkery, John M., Schifano, Fabrizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992390/ https://www.ncbi.nlm.nih.gov/pubmed/29910745 http://dx.doi.org/10.3389/fpsyt.2018.00153

Ejemplares similares

‘New/Designer Benzodiazepines’: An Analysis of the Literature and Psychonauts’ Trip Reports
por: Orsolini, Laura, et al.
Publicado: (2020)

The “Endless Trip” among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review
por: Orsolini, Laura, et al.
Publicado: (2017)

The Psychonauts’ World of Cognitive Enhancers
por: Napoletano, Flavia, et al.
Publicado: (2020)

Evolutionary Considerations on the Emerging Subculture of the E-psychonauts and the Novel Psychoactive Substances: A Comeback to the Shamanism?
por: Orsolini, Laura, et al.
Publicado: (2017)

The Bridge Between Classical and “Synthetic”/Chemical Psychoses: Towards a Clinical, Psychopathological, and Therapeutic Perspective
por: Orsolini, Laura, et al.
Publicado: (2019)

Novel Opioids: Systematic Web Crawling Within the e-Psychonauts’ Scenario
por: Arillotta, Davide, et al.
Publicado: (2020)

The Psychonauts’ Benzodiazepines; Quantitative Structure-Activity Relationship (QSAR) Analysis and Docking Prediction of Their Biological Activity
por: Catalani, Valeria, et al.
Publicado: (2021)

The e-Psychonauts’ ‘Spiced’ World; Assessment of the Synthetic  Cannabinoids’ Information Available Online
por: Zangani, Caroline, et al.
Publicado: (2020)

COVID-19: The Hidden Impact on Mental Health and Drug Addiction
por: Chiappini, Stefania, et al.
Publicado: (2020)

Identifying New/Emerging Psychoactive Substances at the Time of COVID-19; A Web-Based Approach
por: Catalani, Valeria, et al.
Publicado: (2021)

Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review
por: Orsolini, Laura, et al.
Publicado: (2019)

Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration’s FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset
por: Chiappini, Stefania, et al.
Publicado: (2023)

Focus on Over-the-Counter Drugs' Misuse: A Systematic Review on Antihistamines, Cough Medicines, and Decongestants
por: Schifano, Fabrizio, et al.
Publicado: (2021)

Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review
por: Schifano, Fabrizio, et al.
Publicado: (2018)

Assessing the 2004–2018 Fentanyl Misusing Issues Reported to an International Range of Adverse Reporting Systems
por: Schifano, Fabrizio, et al.
Publicado: (2019)

An Insight into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions
por: Schifano, Fabrizio, et al.
Publicado: (2019)

Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database
por: Chiappini, Stefania, et al.
Publicado: (2020)

Beyond the ‘purple drank’: Study of promethazine abuse according to the European Medicines Agency adverse drug reaction reports
por: Chiappini, Stefania, et al.
Publicado: (2021)

Alexithymia and Suicide Risk in Psychiatric Disorders: A Mini-Review
por: De Berardis, Domenico, et al.
Publicado: (2017)

Editorial: “No Words for Feelings, Yet!” Exploring Alexithymia, Disorder of Affect Regulation, and the “Mind-Body” Connection
por: De Berardis, Domenico, et al.
Publicado: (2020)

COVID-19 Pandemic Impact on Substance Misuse: A Social Media Listening, Mixed Method Analysis
por: Arillotta, Davide, et al.
Publicado: (2021)

Alprazolam-related deaths in Scotland, 2004–2020
por: Corkery, John Martin, et al.
Publicado: (2022)

Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics
por: de Vos, Cato M. H., et al.
Publicado: (2021)

Psychedelics and workplace harm
por: Viña, Sean Matthew, et al.
Publicado: (2023)

New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature
por: Chiappini, Stefania, et al.
Publicado: (2021)

A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance Databases
por: Chiappini, Stefania, et al.
Publicado: (2022)

Case Report: Treatment of Kratom Use Disorder With a Classical Tricyclic Antidepressant
por: Vento, Alessandro E., et al.
Publicado: (2021)

The Use of Psychedelics in the Treatment of Medical Conditions: An Analysis of Currently Registered Psychedelics Studies in the American Drug Trial Registry
por: Kurtz, Joshua S, et al.
Publicado: (2022)

Pharmacovigilance Signals of the Opioid Epidemic over 10 Years: Data Mining Methods in the Analysis of Pharmacovigilance Datasets Collecting Adverse Drug Reactions (ADRs) Reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System (FAERS)
por: Chiappini, Stefania, et al.
Publicado: (2022)

Psychedelic therapy in the treatment of addiction: the past, present and future
por: Zafar, Rayyan, et al.
Publicado: (2023)

Commentary: Psychedelic Psychiatry's Brave New World
por: Nobile, Bénédicte, et al.
Publicado: (2020)

Psychedelics and Other Psychoplastogens for Treating Mental Illness
por: Vargas, Maxemiliano V., et al.
Publicado: (2021)

The Readiness of Psychiatrists to Implement Psychedelic-Assisted Psychotherapy
por: Page, Lisa A., et al.
Publicado: (2021)

Suicide during Perinatal Period: Epidemiology, Risk Factors, and Clinical Correlates
por: Orsolini, Laura, et al.
Publicado: (2016)

GLP-1 Receptor Agonists and Related Mental Health Issues; Insights from a Range of Social Media Platforms Using a Mixed-Methods Approach
por: Arillotta, Davide, et al.
Publicado: (2023)

Moral Psychopharmacology Needs Moral Inquiry: The Case of Psychedelics
por: Langlitz, Nicolas, et al.
Publicado: (2021)

How Psychedelic-Assisted Treatment Works in the Bayesian Brain
por: Villiger, Daniel
Publicado: (2022)

Ketamine for Bipolar Depression: Biochemical, Psychotherapeutic, and Psychedelic Approaches
por: Bennett, Raquel, et al.
Publicado: (2022)

The economics of psychedelic-assisted therapies: A research agenda
por: Marseille, Elliot, et al.
Publicado: (2022)

Psychedelic-induced mystical experiences: An interdisciplinary discussion and critique
por: Mosurinjohn, Sharday, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rgb706ajj1revgvqatsqjsldk9